16n. Ortho-fluorofuranyl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide);
17g. Para-methoxyfuranyl fentanyl (N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide);
17r. Para-methylcyclopropyl fentanyl (N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)cyclopropanecarboxamide);
CSB 2.005 History
History:
cr. Affirmative action order under s.
961.11 (4), Stats.,
Register February 2024 No. 818, eff. 2-5-24.
CSB 2.006
CSB 2.006
Adding 5 Synthetic Cannabinoids to Schedule I.
961.14 (4) (tb) 54. Methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido)butanoate, commonly known as MDMB-4en-PINACA.
55. Methyl 2-[[1-(4-fluorobutyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate, commonly known as 4F-MDMB-BUTICA or 4F-MDMB-BICA.
56. N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(pent-4-en-1-yl)-1H-indazole-3-carboxaminde, commonly known as ADB-4en-PINACA.
57. 5-Pentyl-2-(2-phenylpropan-2-yl)pyrido[4,3-b]indol-1-one, commonly known as CUMYL-PEGACLONE or SGT-151.
58. Ethyl 2-[[1-(5-fluoropentyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate, commonly known as 5F-EDMB-PICA or 5F-EDMB-2201.
CSB 2.006 History
History:
cr. Affirmative action order under s.
961.11 (4), Stats.,
Register February 2024 No. 818, eff. 2-5-24.
CSB 2.007
CSB 2.007
Addition of ADB-BUTINACA, alpha-PiHP, and 3-MMC to Schedule I.
961.14 (4) (tb) 32m. N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-butyl-1H-indazole-3-carboxamide, commonly known as ADB-BUTINACA.
961.14 (7) (L) 2m. 3-methylmethcathinone or 2-(methylamino)-1-(3-methylphenyl)propan-1-one, commonly known as 3-MMC.
36m. 4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one, commonly known as alpha-PiHP.
CSB 2.007 History
History:
cr. Affirmative action order under s.
961.11 (4), Stats.,
Register June 2024 No. 822, eff. 6-17-24; correction in (title) made under s.
13.92 (4) (b) 2., Stats.,
Register June 2024 No. 822.
961.14 (2) (qz) 2-methyl AP-237 (1-(2-methyl-4-(3-phenylprop-2-en-1-yl)piperazin-1-yl)butan-1-one);
CSB 2.008 History
History:
cr. Affirmative action order under s.
961.11 (4), Stats.,
Register June 2024 No. 822, eff. 5-20-24; correction made under s.
35.17, Stats.,
Register June 2024 No. 822.
961.14 (2) (xm) 7e. N-desethyl isotonitazene (N-ethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine).
961.14 (2) (xm) 7m. N-piperidinyl etonitazene also known as etonitazepipne (2-(4-ethoxybenzyl)-5-nitro-1-(2-(piperidin-1-yl)ethyl)-1H-benzimidazole).
CSB 2.009 History
History:
cr. Affirmative action order under s. 961.11 (4), Stats., Register October 2024 No. 826, eff. 10-21-24.
APPENDIX
CSB 2.009 Note
Note:
This Appendix contains actions of the Controlled Substances Board that were made prior to April 3, 2023, which were numbered ss.
CSB 2.01 to
2.99.
CSB 2.009 Note
CSB 2.01 Addition of methaqualone to schedule II. The substance known as methaqualone is hereby added to s.
161.16, Stats., schedule II in sub. (6) which subsection is hereby created.
CSB 2.009 History
History:
Cr.
Register, June, 1973, No. 210, eff. 7-1-73.
CSB 2.009 Note
CSB 2.02 Addition of benzphetamine, chlorphentermine, clortermine, mazindol, and phendimetrazine to schedule III. The
substances known as benzphetamine, chlorphentermine, clortermine, mazindol, and phendimetrazine are hereby added to s.
161.18, Stats., schedule III in sub. (2m) (a), (b), (c), (d) and (e) respectively, which subsections are created to read:
CSB 2.009 Note
(2m) Any material, compound, mixture, or preparation which contains any quantity of the following substances having a potential for abuse associated with a stimulant effect on the central nervous system:
CSB 2.009 Note
(a) Benzphetamine
CSB 2.009 Note
(b) Chlorphentermine
CSB 2.009 Note
(c) Clortermine
CSB 2.009 Note
(d) Mazindol
CSB 2.009 Note
(e) Phendimetrazine
CSB 2.009 History
History:
Cr.
Register, October, 1973, No. 214, eff. 11-1-73.
CSB 2.009 Note
CSB 2.03 Addition of fenfluramine to schedule IV. The substance known as fenfluramine is hereby added to s.
161.20, Stats., schedule IV in sub. (2m) (a), which subsection is hereby created to read:
CSB 2.009 Note
(2m) Any material, compound, mixture, or preparation which contains any quantity of the following substances having a potential for abuse associated with a stimulant effect on the central nervous system:
CSB 2.009 Note
(a) Fenfluramine:
CSB 2.009 History
History:
Cr.
Register, October, 1973, No. 214, eff. 11-1-73.
CSB 2.009 Note
CSB 2.04 Addition of amobarbital, pentobarbital, and secobarbital to schedule II; retention of certain forms of amobarbital, pentobarbital and secobarbital in schedule III. (1) Subsection
(7) of s.
161.16, Stats., schedule II is hereby created to read as follows:
CSB 2.009 Note
(7) Unless excepted under federal regulations or listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances:
CSB 2.009 Note
(a) Amobarbital
CSB 2.009 Note
(b) Pentobarbital
CSB 2.009 Note
(c) Secobarbital
CSB 2.009 Note
(2) Paragraphs (m) and (n) of sub. (3), s.
161.18, Stats., schedule III, are hereby created to read as follows:
CSB 2.009 Note
(m) Unless excepted under federal regulations, any compound, mixture, or preparation containing amobarbital, secobarbital, pentobarbital or any salt thereof and one or more other active medicinal ingredients which are not listed in any schedule.
CSB 2.009 Note
(n) Unless excepted under federal regulations, any suppository dosage form containing amobarbital, secobarbital, pentobarbital, or any salt of any of these drugs and approved by the federal food and drug administration for marketing only as a suppository.
CSB 2.009 History
History:
Cr.
Register, July, 1974, No. 223, eff. 8-1-74.
CSB 2.009 Note
CSB 2.05 Addition of drotebanol to schedule I. The substance known as drotebanol is hereby added to s.
161.14, Stats., schedule I in sub. (3), par. (hm), which paragraph is created to read:
CSB 2.009 Note
(hm) Drotebanol;
CSB 2.009 History
History:
Cr.
Register, July, 1974, No. 223, eff. 8-1-74.
CSB 2.009 Note
CSB 2.06 Addition of pentazocine to schedule III. Subsection
(4m) of s.
161.18, Stats., schedule III is hereby created to read as follows:
CSB 2.009 Note
(4m) Pentazocine.
CSB 2.009 History
History:
Cr.
Register, August, 1974, No. 224, eff. 9-1-74.
CSB 2.009 Note
CSB 2.07 Transfer of hydrochloride form of etorphine from schedule I to schedule II. (1) Subsection
(3) (intro.) of s.
161.14, Stats., schedule I is amended to read:
CSB 2.009 Note
(3) Unless specifically excepted or listed in another schedule, any of the following opium derivatives, their salts, isomers and salts of isomers whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation:
CSB 2.009 Note
(2) Paragraph (em) of sub. (3), s.
161.16, Stats., schedule II, is hereby created to read:
CSB 2.009 Note
(em) Etorphine hydrochloride;
CSB 2.009 History
History:
Cr.
Register, August, 1974, No. 224, eff. 9-1-74.
CSB 2.009 Note
CSB 2.08 Addition of poppy straw to schedule II, addition of pemoline and mebutamate to schedule IV. (1) Paragraph (d) of sub. (2), s.
161.16, Stats., schedule II is hereby created to read:
CSB 2.009 Note
(d) Concentrate of poppy straw (the crude extract of Poppy Straw in either liquid, solid or powder form which contains the phenanthrene alkaloids of the opium poppy).
CSB 2.009 Note
(2) Paragraph
(n) of sub.
(2) of s.
161.20, Stats., schedule IV is hereby created to read:
CSB 2.009 Note
(n) Mebutamate
CSB 2.009 Note
(3) Paragraph
(b) of sub.
(2m) of s.
161.20, Stats., schedule IV is hereby created to read:
CSB 2.009 Note
(b) Pemoline:
CSB 2.009 History
History:
Cr.
Register, February, 1976, No. 242, eff. 3-1-76.
CSB 2.009 Note
CSB 2.09 Additions to schedules IV and I. (1)
Addition of benzodiazepine substances to schedule IV. Paragraphs (cm), (cn), (cp), (cr), (em) and (hm) of sub. (2), s.
161.20, Stats., schedule IV are hereby created to read:
CSB 2.009 Note
(cm) Chlordiazepoxide
CSB 2.009 Note
(cn) Clonazepam
CSB 2.009 Note
(cp) Chlorazepate
CSB 2.009 Note
(cr) Diazepam
CSB 2.009 Note
(em) Flurazepam
CSB 2.009 Note
(hm) Oxazepam
CSB 2.009 Note
(2) Addition of the thiophene analog of phencyclidine to schedule I. Paragraph (u) of sub. (4), s.
161.14, Stats., schedule I is hereby created to read:
CSB 2.009 Note
(u) Thiophene analog of phencyclidine
CSB 2.009 Note
(3) Addition of mecloqualone to schedule I. Subsection (5) and par. (a) of s.
161.14, Stats., schedule I are hereby created to read:
CSB 2.009 Note
(5) Depressants. Unless specifically excepted or unless listed in another schedule, any material compound, mixture or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation:
CSB 2.009 Note
(a) Mecloqualone
CSB 2.009 Note
(4) Addition of difenoxin to schedule I. Paragraph (hg) of sub. (2), s.
161.14, Stats., schedule I is hereby created to read:
CSB 2.009 Note
(hg) Difenoxin
